Palomar Medical Technologies Inc - Current report filing (8-K)
03 3월 2008 - 10:02PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 29, 2008
Palomar Medical Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware
(State or other jurisdic-
tion of incorporation)
|
0-22340
(Commission
File Number)
|
04-3128178
(IRS Employer
Identification Number)
|
|
82 Cambridge Street, Burlington, Massachusetts 01803
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (781) 993-2300
(Former Name or Former Address, if Changed Since Last Report)
|
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On February 29, 2008, Palomar Medical Technologies, Inc. (the “Company”), a Delaware corporation, and The Procter & Gamble
Company (NYSE: PG) and its wholly-owned subsidiary, The Gillette Company, entered into a License Agreement. The Company’s press
release announcing this agreement is entitled “Palomar and P&G Enter New License Agreement” and is filed as Exhibit 99.1 to this
Current Report on Form 8-K.
The description above is qualified in its entirety by reference to the License Agreement, copies of which are attached to
this Current Report on Form 8-K as Exhibit 10.1 and incorporated by reference.
|
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
|
|
Number
|
Title
|
|
|
|
|
10.1*
|
License Agreement executed on February 29, 2008 and effective as
of February 14, 2003, between Palomar Medical Technologies, Inc. and The Procter & Gamble Company and its
wholly-owned subsidiary The Gillette Company.
|
|
|
|
|
99.1
|
Press Release issued by Palomar Medical Technologies, Inc. on March 3, 2008
|
|
|
|
|
*
|
Portions of this exhibit have been omitted subject to a pending request for confidential treatment under Rule 24b-2 of the
Securities Exchange Act of 1934, and in connection with that request an unredacted copy of this exhibit has been filed with the SEC.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
|
PALOMAR MEDICAL TECHNOLOGIES, INC.
|
|
|
By: /s/ Joseph P. Caruso
——————————————
Chief Executive Officer and President
|
|
Number
|
Title
|
|
|
|
|
10.1*
|
License Agreement executed on February 29, 2008 and effective as
of February 14, 2003, between Palomar Medical Technologies, Inc. and The Procter & Gamble Company and its
wholly-owned subsidiary The Gillette Company.
|
|
|
|
|
99.1
|
Press Release issued by Palomar Medical Technologies, Inc. on March 3, 2008
|
|
|
|
|
*
|
Portions of this exhibit have been omitted subject to a pending request for confidential treatment under Rule 24b-2 of the
Securities Exchange Act of 1934, and in connection with that request an unredacted copy of this exhibit has been filed with the SEC.
|
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Palomar Medical Technologies, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Palomar Medical Technologies Inc News Articles